Taking vitamin E does not impact women’s heart failure risk

March 20, 2012 Categories: Heart News
Study Highlights:
  • Long-term vitamin E supplementation does not affect heart failure risk among women.
  • Strategies aimed at lowering women’s heart failure risk should focus on what has been shown to work, including blood pressure management and heart disease prevention.
EMBARGOED UNTIL 3 pm CT/4 pm ET, Tuesday, Mar. 20
DALLAS, March 20, 2012 —Taking vitamin E supplements does not increase or decrease heart failure risk among women, according to a study in Circulation: Heart Failure, an American Heart Association journal.
The study is the first to investigate the effectiveness of vitamin E to prevent the development of heart failure. Researchers studied nearly 40,000 women in the Women’s Health Study who took 600 International Units of vitamin E or placebo every other day. The women were age 45 or older and healthy at the study’s start. Researchers followed them for an average 10.2 years to determine if taking the supplement affected heart failure risk. Investigators recorded 220 heart failure cases.
Overall, researchers found no impact from vitamin E supplementation. They did, however, observe a 41 percent decrease in the risk of developing a type of heart failure in which the heart retains its normal pumping function. This sub finding is only an observation and topic for future research, said Claudia U. Chae, M.D., M.P.H, lead researcher in the cardiology division at Massachusetts General Hospital in Boston.
They conclude: vitamin E does not prevent heart failure. Prevention strategies should instead focus on what has been shown in research to reduce heart failure risk, such as controlling blood pressure and preventing heart disease.
More than six million American adults suffer from heart failure, a chronic, progressive condition in which the heart muscle is unable to pump enough blood to meet the body's blood and oxygen needs.
Co-authors are: Christine M. Albert, M.D., M.P.H.; MV Moorthy, Ph.D.; I-Min Lee, Sc.D.; and Julie E. Buring, Sc.D. Author disclosures and funding information are available on the abstract.
Statements and conclusions of study authors published in American Heart Association scientific journals are solely those of the study authors and do not necessarily reflect the association’s policy or position. The association makes no representation or guarantee as to their accuracy or reliability. The association receives funding primarily from individuals; foundations and corporations (including pharmaceutical, device manufacturers and other companies) also make donations and fund specific association programs and events. The association has strict policies to prevent these relationships from influencing the science content. Revenues from pharmaceutical and device corporations are available at www.heart.org/corporatefunding.
NR12 –1039 (Circ HF/Chae)
Additonal resources, including multimedia, are available in the right column. 
Additional Resources:
For Media Inquiries: (214) 706-1173
For other information, contact:
Carrie Thacker (214) 706-1665; carrie.thacker@heart.org
Karen Astle (214) 706-1392; karen.astle@heart.org
Julie Del Barto (broadcast): (214) 706-1330; Julie.Del.Barto@heart.org
For Public Inquiries: (800) AHA-USA1 (242-8721)